![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, October 17, 2023 2:11:56 PM
Mar 24, 2021: "The Company is on track to meet its planned enrollment goal for the Study in Q2-2021."
July 15, 2021: "Aim to complete enrollment in Q3-2021 and FDA EUA submission in late-Q3/Q4-2021."
Oct 26, 2021: "Expect to complete enrollment in Q4-2021."
Dec 29, 2021: "Expected to complete enrollment in Q1-2022."
Jan 18, 2022: "On-track to complete enrollment in Q1-2022 and FDA submission thereafter."
Mar 29, 2022: "The Company now expects to complete full enrollment in Q2-2022."
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM